{"id":"W2901760736","doi":"10.1016/s1470-2045(18)30576-x","title":"Targeting B-cell maturation antigen with GSK2857916 antibody–drug conjugate in relapsed or refractory multiple myeloma (BMA117159): a dose escalation and expansion phase 1 trial","year":2018,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":244,"is_retracted":false,"has_abstract":false,"ca_institutions":"Vancouver General Hospital; Princess Margaret Cancer Centre","funders":"UCLH Biomedical Research Centre; National Cancer Institute; Cancer Research UK; National Institutes of Health; National Institute for Health and Care Research; GlaxoSmithKline; American Society of Hematology","keywords":"Conjugate; Antibody-drug conjugate; Multiple myeloma; Medicine; Refractory (planetary science); Antibody; Cancer research; Drug; Oncology; Antigen; Internal medicine; Pharmacology; Immunology; Monoclonal antibody; Materials science","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001599798,0.001723088,0.002638297,0.000529692,0.0003961035,0.001428693,0.001039509,0.001822328,0.004490836],"category_scores_gemma":[0.0009747857,0.000587056,0.001994254,0.0004839556,0.001067965,0.001125595,0.0006647808,0.005462258,0.001443494],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001314556,"about_ca_system_score_gemma":0.001217865,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001064897,"about_ca_topic_score_gemma":0.002180942,"domain_scores_codex":[0.9995448,0.0001546121,0.0000205667,0.00008485031,0.00006070274,0.0001344701],"domain_scores_gemma":[0.9994588,0.00008662958,0.00009805424,0.00005179652,0.00002711487,0.0002775115],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6324546,0.05207065,0.003386441,0.001762668,0.00319204,0.0004426111,0.0005247932,0.005288121,0.04835958,0.001439791,0.01541033,0.2356684],"study_design_scores_gemma":[0.746617,0.2391482,0.004521256,0.00006344775,0.0005461592,0.0003044969,0.00005153879,0.001373452,0.003506788,0.0005250233,0.003299087,0.00004372815],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9906944,0.002816122,0.000418411,0.001092946,0.0002125696,0.001391314,0.0009191958,0.0001907367,0.002264245],"genre_scores_gemma":[0.984697,0.003158166,0.001587982,0.001852355,0.0001658403,0.001736315,0.00234259,0.00007143417,0.004388342],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004490836,"threshold_uncertainty_score":0.01502329,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0496385688750652,"score_gpt":0.384529794605185,"score_spread":0.3348912257301199,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}